Ken Griffin Eton Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,300 shares of ETON stock, worth $83,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,300
Previous 28,500
49.82%
Holding current value
$83,512
Previous $106,000
55.66%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ETON
# of Institutions
47Shares Held
8.16MCall Options Held
41KPut Options Held
1K-
Opaleye Management Inc. Boston, MA2.4MShares$14 Million2.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT941KShares$5.49 Million0.21% of portfolio
-
Westside Investment Management, Inc.585KShares$3.42 Million0.44% of portfolio
-
Acuitas Investments, LLC580KShares$3.39 Million1.08% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $148M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...